OCUL Ocular Therapeutix Net earnings per share (EPS TTM)

OCUL (Ocular Therapeutix Corp) - company brandmark

Cost optimization through the automation of hydrogel implant production is improving cash flows for Ocular Therapeutix (OCUL). The rolling trailing twelve-month net income per share visualizes this trend, where the value -1.47 captures this metric. Despite the risks of single-product dependency, Ocular Therapeutix (OCUL) is expanding its clinical portfolio by developing innovative gel systems for glaucoma therapy and the treatment of dry eye syndrome.

OCUL Ocular Therapeutix Net earnings per share for the last four quarters (07/04/2022 - 11/18/2026)

OCUL (Ocular Therapeutix): analytical breakdowns and indicator data

- share price and expert price forecast:
Analysis of all company metrics:OCUL - Ocular Therapeutix, Inc.
Manufactured products of Ocular Pharma

To build a high-quality portfolio, I evaluate the business's ability to generate real earnings per common share, which allows for a comparison of the market value of Ocular Therapeutix (OCUL) with its fundamental backing. The trend in net income per share over the last 12 months reflects the efficiency of monetizing unique hydrogel technologies, converting surgeon confidence into concrete financial results for every shareholder.

Competitor analysis for Ocular Therapeutix

Alcon Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Bausch + Lomb|GKOS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Apellis Corp (APLS)|Earnings per share for the last twelve months Belite Bio|Harrow, Inc. (HROW) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months VRDN (Viridian Therapeutics, Inc.)|Earnings per share for the last twelve months LENZ (LENZ Therapeutics)|Earnings per share for the last twelve months Oculis AG OCS|EyePoint Pharma (EYPT) - Net earnings per one share for the last twelve months|kodiak.com - Net earnings per share (EPS TTM)|ALDX (aldeyra.com) - Earnings per share for the last 12 months|KALA: Net earnings per share (EPS TTM)|Opus Genetics, Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months OKYO|ADVM: Earnings per share for the trailing year|Earnings per share for the last twelve months Outlook Therapeutics Inc (OTLK)|Net earnings per share for the last four quarters Clearside Biomedical|NovaBay Pharmaceuticals - Net earnings per share for the last 12 months|KPRX (Kiora Pharma) - Earnings per one share for the last 12 months|ALIM: Net earnings per share for the last 12 months|EYEN - Net earnings per share (EPS TTM)|GHSI (Guardion Health Science) - Net earnings per share for the last 12 months|ocuphire.com - Earnings per share for the trailing year|OPT (Opthea Ltd) - Net earnings per share (EPS TTM)